Simian parvovirus |
| |
| Institution: | 1. UCL Division of Surgery and Interventional Science, University College London, Charles Bell House, 43-45 Foley Street, London, W1W 7TS, UK;2. Clinical Pharmacology and Therapeutics Group, University College London, School of Pharmacy, BMA House, Tavistock Square, London, WC1H 9JP, UK;3. ToxPath Consultancy Ltd, Church Road, Wingfield, Diss, IP21 5RA, UK;4. Nanoco Technologies Ltd, 46 Grafton Street, Manchester M13 9NT, UK;1. Department of Testing and Certification, Taiwan Textile Research Institute, New Taipei 23674, Taiwan;2. Department of Engineering and System Science, Institute of Nuclear Engineering and Science, and Low Carbon Energy Research Center, National Tsing Hua University, Hsinchu 30013, Taiwan |
| |
| Abstract: | Parvovirus B19 is currently the only member of theErythrovirusgenus. Recently a second parvovirus, simian parvovirus, was identified in cynomolgus monkeys which also appeared to be highly tropic for erythroid progenitor cells. This review describes the identification of this new arrival parvovirus and summarizes current knowledge of its clinical, molecular and epidemiological features. The virus has many biological similarities to the parvovirus B19 and close homology to the B19 genome at the molecular level, both of which justify the inclusion of this novel virus as a new member of theErythrovirusgenus. |
| |
| Keywords: | |
| 本文献已被 ScienceDirect 等数据库收录！ |
|
